U.S. pharma giant copyright scrapped two experimental weight loss capsules final yr—a at the time-every day pill, lotiglipron, due to elevated liver enzymes as well as a two times-each day pill, danuglipron, resulting from sturdy Unwanted effects—but CEO Albert Bourla has said the co